ArticleCancer chemotherapy and pharmacology2023

Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumors.

Mats Någård et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.